New molecular experiments have supplied numerous insights into the processes that govern the event and development of CLL, which includes lots of novel mutated genes clustered in different useful pathways. The CLL epigenome is reprogrammed with the modulation of regulatory regions that surface de novoIn many conditions, these molecular drivers keep